e-learning
resources
Munich 2014
Sunday, 07.09.2014
Airway biomarkers
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control
Z. Tzilogianni, P. Bakakos, A. I. Papaioannou, A. Papaporfyriou, G. Hillas, S. Papiris, N. Koulouris, S. Loukides, K. Kostikas (Athens, Greece)
Source:
International Congress 2014 – Airway biomarkers
Session:
Airway biomarkers
Session type:
Thematic Poster Session
Number:
1001
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Z. Tzilogianni, P. Bakakos, A. I. Papaioannou, A. Papaporfyriou, G. Hillas, S. Papiris, N. Koulouris, S. Loukides, K. Kostikas (Athens, Greece). Sputum interleukin (IL)-13 as a biomarker for the evaluation of asthma control. Eur Respir J 2014; 44: Suppl. 58, 1001
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: What’s NEW in the 2022 ERS/ATS PFT Interpretation Statement
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Diagnostic accuracy of markers for detection of airway eosinophilia in asthma: A systematic review
Source: International Congress 2014 – Airway biomarkers
Year: 2014
Sputum YKL-40 is a potential biomarker of COPD-asthma overlap
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Biomarkers for sputum eosinophilia in mild-moderate and severe adult-onset asthma patients
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Serum periostin in asthma: A potential biomarker for stratification in severe treatment-resistant asthma
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Importance of concomitant local and systemic eosinophilia in uncontrolled asthma
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014
The usefulness of FeNO and the mannitol test in detecting airway eosinophilia in asthma patients with uncontrolled symptoms
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014
U-BIOPRED asthma cohort: Inflammatory markers and corticosteroid use
Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management
Year: 2013
Urinary LTE
4
may be associated with TH2-driven asthma: Initial data from the Pan-European U-BIOPRED IMI project
Source: International Congress 2014 – Biomarkers of asthma control
Year: 2014
Evaluation of inflammatory markers IL-6 and MMP-9 in asthma
Source: International Congress 2015 – Clincal aspects of asthma: monitoring and mechanisms
Year: 2015
Influence of psychological characteristics of patients for asthma control
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014
Asthma control is not related to large airways function
Source: International Congress 2014 – Monitoring airway diseases with lung function tests
Year: 2014
Hydrogen sulphide as a biomarker in COPD and asthma
Source: International Congress 2014 – Systemic biomarkers for airway diseases
Year: 2014
Implication of IL-18 in the chronic inflammation of severe refractory asthma
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Sputum neutrophil differential cell count in health and relationship to disease severity in asthma
Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Year: 2014
Conduct of a biomarker study in bronchiectasis patients: Correlation of neutrophil elastase activity and inflammatory load in induced sputum
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
The potential role of bronchial challenge testing to identify overtreatment of community managed asthma
Source: International Congress 2014 – Phenotyping and monitoring asthma and COPD
Year: 2014
The effects of oral care on FeNO measurement in asthmatic patients
Source: International Congress 2014 – Airway biomarkers
Year: 2014
The course and outcomes of pregnancy in women with bronchial asthma
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014
Osteopontin and periostin in bronchial tissue associate with a 20-year decline of pulmonary function in asthmatics
Source: International Congress 2014 – Systemic and airway biomarkers
Year: 2014
Induced sputum lipid mediators in severe asthma
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept